355sek
1,7 %
Date:2025-06-04Time:18:00:00Latest report:Q1-2025List:First NorthTicker:ALZCUR
Market Cap:313 msekEnterprise Value:293 msekNet Sales:- msekEarnings:-35,5 msekEmployees:0ISIN:SE0010133785

Ratios

10-year key figure history for AlzeCure Pharma turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AlzeCure Pharma with index and moving average MA50 and MA200.

Stockprice:3,55
MA50:2,53
MA200:1,88
Price/MA200:88,5 %
RSI (14):80,3
Price/MA50:40,6 %

Description

AlzeCure Pharma is a pharmaceutical company. The company focuses on research and development of drugs used for various brain diseases, with the greatest focus on Alzheimer's disease, but also on pain. The technology and research is based on its own pharmaceutical platform, where the company develops various symptom-relieving and disease-modifying drug candidates. The head office is in Huddinge.

Pharmaceuticals